NEW YORK, Jan. 10, 2018 -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Intel Corporation (“Intel” or the “Company”) (NASDAQ:INTC) of the March 12, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
If you invested in Intel stock or options between July 27, 2017 and January 4, 2018 and would like to discuss your legal rights, click here: www.faruqilaw.com/INTC. There is no cost or obligation to you.
You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected].
CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
[email protected]
Telephone: (877) 247-4292 or (212) 983-9330
The lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all those who purchased Intel securities between July 27, 2017 and January 4, 2018 (the “Class Period”). The case, Alvira v. Intel Corporation, Inc. et al, No. 2:18-cv-00223 was filed on January 10, 2018.
The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) there is a fundamental design flaw in Intel’s processor chips as they contain a feature that makes them vulnerable to hacking; (2) updates to fix the problems in Intel’s processor chips could cause Intel chips to operate 5-30 percent more slowly; and (3) as a result, Intel’s public statements were materially false and misleading at all relevant times.
Specifically, after market close on January 2, 2018, The Register published an article stating that there is a “fundamental design flaw in Intel’s processor chips” and updates to fix the problems could cause Intel chips to operate 5-30 percent more slowly. Then on January 3, 2018, Intel published an article on its website confirming that its chips contain a feature that makes them vulnerable to hacking. On this news, Intel’s share price fell from $46.85 per share on January 2, 2018 to a closing price of $45.26 on January 3, 2018—a $1.59 or a 3.39% drop.
Then, on January 4, 2018, multiple news outlets reported that Intel’s Chief Executive Officer, Brian Krzanich, sold millions of dollars worth of the Company’s shares after Intel was informed of vulnerabilities in its semiconductors, but before the vulnerabilities were publicly disclosed. On this news, Intel’s share price fell from $45.26 per share on January 3, 2018 to a closing price of $44.43 on January 4, 2018—a $0.83 or a 1.83% drop.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Intel’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.


Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Anta Sports Expands Global Footprint With Strategic Puma Stake
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



